Cargando…
Arsenic sulfide reverses cisplatin resistance in non‐small cell lung cancer in vitro and in vivo through targeting PD‐L1
BACKGROUND: Recent studies have found that programmed death ligand 1 (PD‐L1) might be involved in chemotherapy resistance in non‐small cell lung cancer (NSCLC). Arsenic sulfide (As(4)S(4)) has been recognized to have antitumor activities and enhance the cytotoxic effect of chemotherapy drugs. In thi...
Autores principales: | Tian, Wei, Sun, Yinping, Cheng, Yuping, Ma, Xiao, Du, Weina, Shi, Wenna, Guo, Qisen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487818/ https://www.ncbi.nlm.nih.gov/pubmed/34469060 http://dx.doi.org/10.1111/1759-7714.14136 |
Ejemplares similares
-
Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo
por: Zhang, Lian, et al.
Publicado: (2015) -
Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo
por: Liu, Xiaoqiang, et al.
Publicado: (2019) -
Speciation of arsenic in sulfidic waters
por: Wilkin, Richard T, et al.
Publicado: (2003) -
Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo
por: Zhang, Lian, et al.
Publicado: (2014) -
Arsenic sulfide as a potential anti-cancer drug
por: DING, WENPING, et al.
Publicado: (2015)